Tag Archives: Procrit

For-Profit Dialysis Centers May Have Ignored Anemia Drug Warnings: Study

May 17, 2013 By: Irvin Jackson
Drug Maker Overhyped, Oversold Anemia Meds: Report

July 24, 2012 By: Ricky Allen
Eprex Recall Issued by Johnson & Johnson Due to Potency Issue

September 26, 2011 By: Staff Writers
Epogen, Aranesp Misuse Rampant: Study

August 10, 2011 By: Staff Writers
Aranesp, Procrit and Epogen Health Risks Call For Lower Doses: FDA

June 27, 2011 By: Staff Writers
Epogen, Procrit May Increase Heart Attack Damage: Study

May 17, 2011 By: Staff Writers
Keppra Stevens-Johnson Syndrome Risk Being Evaluated by FDA

February 02, 2011 By: Staff Writers
Use of Anemia Drugs for Kidney Failure Supported by FDA Panel

October 19, 2010 By: Staff Writers
Procrit and Epogen Recall Issued Over Glass Flakes in Vials

September 27, 2010 By: Staff Writers
Anemia Drugs Increase Risk of Heart Problems, Death in Some Cases: Study

September 20, 2010 By: Staff Writers

Lawyers in Hair Relaxer Cancer Lawsuits Fail To Reach Agreement on Bellwether Plan (Posted 5 days ago)

Judge presiding over all federal hair relaxer lawsuits has ordered the parties to submit separate briefing on the bellwether selection process by January 3.

Depo-Provera Lawsuit MDL Application Will Be Considered by JPML at Hearing on Jan. 30, 2025 (Posted 6 days ago)

With a growing number of women pursuing Depo-Provera brain tumor lawsuits throughout the federal court system, the U.S. JPML will decide whether to consolidate and centralize the claims before one judge for coordinated discovery and pretrial proceedings.

AngioDynamics Port Catheter Lawyers Seek Leadership Roles in MDL (Posted 7 days ago)

A proposal has been submitted for a group of 12 lawyers involved in AngioDynamics port catheter lawsuits to serve in various leadership positions in the litigation, which involves dozens of claims that the implants were defectively designed, leading to fractures, migration and infections.

Tag Archives: Procrit

For-Profit Dialysis Centers May Have Ignored Anemia Drug Warnings: Study

Drug Maker Overhyped, Oversold Anemia Meds: Report

Eprex Recall Issued by Johnson & Johnson Due to Potency Issue

Epogen, Aranesp Misuse Rampant: Study

Aranesp, Procrit and Epogen Health Risks Call For Lower Doses: FDA

Epogen, Procrit May Increase Heart Attack Damage: Study

Keppra Stevens-Johnson Syndrome Risk Being Evaluated by FDA

Use of Anemia Drugs for Kidney Failure Supported by FDA Panel

Procrit and Epogen Recall Issued Over Glass Flakes in Vials

Anemia Drugs Increase Risk of Heart Problems, Death in Some Cases: Study

More Top Stories

Review A Case